Agenda

1:00 p.m.  Registration

1:30 p.m.  Opening remarks

• Allan Brilliant, Partner, Dechert LLP

1:40 p.m.  Rx for the future: how will a slowdown impact the pharmaceutical and bio-tech industries?  

For drug makers a restructuring means cost-cutting campaigns, falling sales and consolidating locations. Bio-tech companies could also be backed into the corner by major changes from a down economy that limit research capabilities and make raising funds harder than ever. Add to that the current regulatory environment which is creating more challenges and more innovative solutions. Hear our panelists’ expectations for the number of insolvencies caused by these industry challenges and their advice to seek opportunities in these converging sectors.  

Moderator

• Michael Sage, Partner, Dechert LLP

Panelists

• Ashish Contractor, Managing Director, Moelis & Company
• Barak Klein, Managing Director, Moelis & Company
  
• David Orlofsky, Managing Director, AlixPartners
• David Rosenthal, Partner, Dechert LLP

2:25 p.m.  Networking break

2:45 p.m.  The intersection of product liability, mass torts and bankruptcy 

Wildfires, opioids, talc and asbestos (yet again) are making headlines all over the world. The estimates of these complex claims, increased litigation brought by both individual and governmental plaintiffs and valuation of a reorganization are causing dramatic changes across the industry. Join the panelists as they uncover what past issues may soon repeat themselves (with new twists) and examine creative ways to address these concerns in future cases.

Moderator

• Sheila Birnbaum, Partner, Dechert LLP

Panelists

• Sam Issacharoff, Reiss Professor, NYU Law School
• Jamie O’Connell, Partner, PJT Partners
• Timothy G. Raab, Senior Managing Director, Ankura
• Shmuel Vasser, Partner, Dechert LLP

3:35 p.m.  One world with multiple restructuring regimes: hot topics in cross border restructurings 

While today’s business environment is truly global, in local markets specific regulation, legislation, politics, demographics and culture materially impact corporate restructurings and insolvencies. This session will explore hot topics in restructuring multinational companies in the United States, United Kingdom, emerging markets and across the globe.

Moderator

• Allan Brilliant, Partner, Dechert LLP

Panelists

• Kofi Bentsi, Portfolio Manager, PIMCO
• Austin Camporin, Associate Portfolio Manager, Elliott Management Corporation
• Brock Edgar,  Senior Managing Director, FTI Consulting
• Edward Janger, David M. Barse Professor of Law & Associate Dean for Faculty Research and Scholarship, Brooklyn Law School
• Robert Rauch, Senior Partner, Portfolio Manager, Gramercy

4:20 p.m. Closing remarks

• Michael Sage, Partner, Dechert LLP

4:30 p.m. Reception

Click here to view the 2018 Dechert Distressed Investing Forum Post-Event Summary